OnKure Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Muralidhar Bali | — | Purchase | 5,915 | $9.38 | $55,483 | 1,864,141 | May 27, 2021 |
| NEA 15 GP, LLC | — | Purchase | 666,666 | $15.00 | $9,999,990 | 4,785,494 | Apr 13, 2021 |
| O'Donnell Niall | — | Purchase | 200,000 | $15.00 | $3,000,000 | 2,063,713 | Apr 13, 2021 |
| Muralidhar Bali | — | Purchase | 200,000 | $15.00 | $3,000,000 | 1,858,226 | Apr 13, 2021 |
| GREY MICHAEL G | Executive Chairman | C | 20,162 | — | — | 444,762 | Apr 13, 2021 |
| Novo Holdings A/S | — | C | 2,763,711 | — | — | 2,763,711 | Apr 13, 2021 |
| RiverVest Venture Fund IV, L.P. | — | C | 829,113 | — | — | 2,209,220 | Apr 9, 2021 |